Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 901.19 |
| Open | 901.26 |
| Bid | 825.40 x 100 |
| Ask | 893.98 x 100 |
| Day's range | 892.15 - 908.81 |
| 52-week range | 684.81 - 998.33 |
| Volume | |
| Avg. volume | 469,583 |
| Market cap | 98.126B |
| Beta (5Y monthly) | 0.14 |
| PE ratio (TTM) | 25.69 |
| EPS (TTM) | 34.80 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1,048.72 |
ZacksBiotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
ZacksWhy Regeneron (REGN) Could Beat Earnings Estimates Again
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
© 2024 Yahoo. All rights reserved.